Gene signatures in breast cancer: current and future uses.
about
HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.Intratumoral and peritumoral lymphatic vessel density both correlate with lymph node metastasis in breast cancerRole of inflammatory infiltrates in triple negative breast cancer.Integrated miRNA and mRNA profiling of tumor-educated macrophages identifies prognostic subgroups in estrogen receptor-positive breast cancer.Refinement of breast cancer risk prediction with concordant leading edge subsets from prognostic gene signatures.
P2860
Gene signatures in breast cancer: current and future uses.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Gene signatures in breast cancer: current and future uses.
@ast
Gene signatures in breast cancer: current and future uses.
@en
type
label
Gene signatures in breast cancer: current and future uses.
@ast
Gene signatures in breast cancer: current and future uses.
@en
prefLabel
Gene signatures in breast cancer: current and future uses.
@ast
Gene signatures in breast cancer: current and future uses.
@en
P2093
P2860
P356
P1476
Gene signatures in breast cancer: current and future uses.
@en
P2093
Angelo Gámez-Pozo
Enrique Espinosa Arranz
Juan Ángel Fresno Vara
Pilar Zamora
P2860
P304
P356
10.1593/TLO.12244
P577
2012-12-01T00:00:00Z